BELLUSCURA PLC
BELL.L
39.0
1.50
(4.00%)
Market Open
As on 26 Sep, 2023, 11:00 AM
Market Cap
70.55 M
P/E Ratio
-6.50
Div Yield
0.00%
Volume
204,119.00
Eps
-0.06
Previous Close
$37.50
Day Range
35.1 - 39.98
Year Range
23.0 - 79.7
Overall Rating
No data
Novacyt S.A.
NCYT.L
$63.50
Renalytix Plc
RENX.L
-4.51%
$82.37
Arecor Therapeutics plc
AREC.L
-0.16%
$195.00
ANGLE plc
AGL.L
1.30%
$14.60
Polarean Imaging plc
POLX.L
-7.30%
$10.00
Equals Group plc
EQLS.L
1.52%
$115.64
e-therapeutics plc
ETX.L
1.44%
$12.30
Faron Pharmaceuticals Oy
FARN.L
2.71%
$320.00
Sourcebio International Plc
SBI.L
-3.03%
$115.00
Creo Medical Limited
CREO.L
4.55%
$31.49
Tekcapital plc
TEK.L
-1.59%
$12.56
Advanced Oncotherapy plc
AVO.L
-3.35%
$1.75
Diaceutics PLC
DXRX.L
-9.09%
$105.00
Scancell Holdings plc
SCLP.L
-3.67%
$16.99
10.49%
No data
No data
|
Date
|
Consensus EPS
|
Eps
|
Consensus Revenue
|
Revenue
|
|---|---|---|---|---|
|
Sep 18
|
N/A | N/A | N/A | N/A |
|
Sep 17
|
N/A | N/A | N/A | N/A |
|
Sep 13
|
N/A | N/A | N/A | N/A |
|
Sep 12
|
N/A | N/A | N/A | N/A |
|
Jun 29
|
N/A | N/A | N/A | N/A |
BELL.L Profile
Industry:
Medical Devices
Sector:
Healthcare
CEO:
Mr. Robert Rauker
Exchange:
London Stock Exchange
London
Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.